Fig. 5From: Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)Forest plots depicting recurrence incidence reported in the included studies. ORs are shown with 95% CIsBack to article page